Annie Umbricht, M.D.

Assistant Professor of Psychiatry
Assistant Professor of Internal Medicine

Education

College Classique – Switzerland (CH), B.C., 1966-1974, German-Latin-English
Université de Lausanne, Faculté de Médecine - CH, M.D., 1974-1980, Medicine
University of Kiel Hospital, West Germany, 1981-1982, Internship, Anesthesia
Delemont regional Hospital, Univ. Basel affiliated - CH, 1982-1983, Intern, Internal Medicine
University of Basel - CH, 1983-1985, Intern-resident, General Surgery
Francis Scott Key Medical Center, Johns Hopkins University, 1986-1988, Resident, Internal Medicine
Johns Hopkins Uniersity School of Medicine, 1988-1991, Fellow, Internal Medicine
Johns Hopkins Uniersity School of Medicine, 1988-1991, Fellow, Psychiatry

Employment

Private Practice Internal Medicine (B. K. Yorkoff M.D.), Towson, MD, October 1991-January 1993
Medical Director, Addiction Services, Attending-Active staff, Internal Medicine, Breater Baltimore Medical Center, Baltimore, February 1993-August 1993
Medical Director, Archway Clinic, National Institute on Drug Abuse, Intramural Research Program, Baltimore MD, February 1993-June 2001
Clinical Acting Director, National Institute on Drug Abuse, Intramural Research Program, Baltimore MD, September 1994-May 1995
Instructor of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, 1995-2001
Active Medical Staff, Internal Medicine, Johns Hopkins Bayview , Baltimore, MD, Januray 1998-June 2001
Medical Director, Sinai Hospital Addiction Recovery Program, Baltimore, MD, July 2001-February 2002
Assistant Professor, Behavioral Pharmacology Research Unit, Psychiatry, Johns Hopkins Univ School of Med, Baltimore, MD, September 2002-present
Assistant Professor, Internal Medicine, Johns Hopkins University School of Med, Baltimore, MD, September 2002-present

Selected peer-reviewed publications

Umbricht-Schneiter, A., Moore, R.D., Santora, P. (1991). Alcohol Abuse: a comparison of two Methods for measuring its Prevalence and associated Morbidity in hospitalized Patients. The American Journal of Medicine, 91, 110-118.

Umbricht-Schneiter, A., Ginn, D.H., Pabst, K.M., Bigelow, G.E. (1994). Providing medical Care to Methadone Clinic Patients: A controlled Study of Referral versus On-Site Care. American Journal of Public Health, 84, 207-210.

Montoya, I.D., Umbricht, A., Preston, K.L. (1995). Buprenorphine for Human Immunovirus Positive Opiate-Dependent Patients. Biological Psychiatry, 38, 135-136.

Umbricht-Schneiter, A., Montoya, I., Preston, K.L. (1995). Factors associated with clonidine use during a short inpatient detoxification with buprenorphine. Journal of Addictive Disease, 14, 154.

Silverman, K., Wong, C.J., Higgins, S.T., Brooner, R.K., Montoya, I.D., Contoreggi, C., Umbricht-Schneiter, A., Schuster, C.R., Preston, K.L. (1996). Increasing Opiate Abstinence Through Voucher-based Reinforcement Therapy. Drug and Alcohol Dependence, 41, 157-165.

Silverman, K., Wong, C.J., Umbricht-Schneiter, A., Montoya, I.D., Schuster, C.R., Preston, K.L. (1998). Broad Beneficial Effects of Reinforcement of Cocaine Abstinence in Methadone Patients. Journal of Consulting and Clinical Psychology, 66, 811-824.

Preston, K.L., Huestis, M.A., Wong, C.J., Umbricht, A., Goldberger, B.A., Cone, E.J. (1999). Monitoring Cocaine Use in Substance Abuse Treatment Patients by Sweat and Urine Testing. Journal of Analytical Toxicology, 23, 313-322.

Preston, K.L., Silverman, K., Umbricht, A., DeJesus, A., Montoya, I.D., Schuster, C.R. (1999). Improvement in Naltrexone Treatment Compliance with Contingency Management. Alcohol and Drug Dependence, 54,127-135.

Umbricht, A., Montoya, I.D., Hoover, D.R., Demuth, K.L., Chiang, C.T., Preston, K.L. (1999). Naltrexone-Shortened Opioid Detoxification with Buprenorphine. Alcohol and Drug Dependence, 56, 181-190.

Preston, K.L., Huestis, M.A., Wong, C.J., Umbricht, A., Goldberger, B.A., Cone, E.J. (1999). Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testing. (1999) Journal of Analytical Toxicology, 23, 313-322.

Preston, K.L., Umbricht, A., Epstein, D.H. (2000). Methadone Dose Increase and Abstinence Reinforcement for Treatment of continued Heroin Use. Archives of General Psychiatry, 57, 395-404.

Huestis, M.A., Cone, E.J., Wong, C.J., Umbricht, A., Preston, K.L. (2000). Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing. Journal of Analytical Toxicology, 24, 509-521.

Pickens, R.W., Preston, K.P., Miles, D.A., Gupman, A.E., Johnson, E.O., Newlin, E.B., Soriano, J., Van den Bree, M.B., Umbricht, A. (2001). Family history influence on drug abuse severity and treatment outcome. Drug Alcohol Dependence, 61, 261-270.

Moolchan, E.T., Umbricht, A., Epstein, D.H. (2001). Therapeutic Drug Monitoring in Methadone Maintenance: Choosing a Matrix. Journal of Addictive Diseases, 20, 55-73.

Preston, K.L., Epstein, D.E., Umbricht, A. (2001). Shaping Cocaine Abstinence by Successive Approximation. The Journal of Consulting and Clinical Psychology, 69, 643-654.

King, V.L., Stoller, K.B., Hayes, M., Umbricht, A., Curran, M., Kidorf, M., Karter, J.A., Schwartz, R., Brooner, R.K. (2002). A multicenter randomized evaluation of methadone medical maintenance. Drug and Alcohol Dependence, 65, 137-148.

Preston KL, Umbricht A, Epstein DH. (2002). Abstinence reinforcement maintenance contingency and one-year follow-up. Drug and Alcohol Dependence, 67, 125-137.

Herning, R.I., Better, W.E., Tate, K., Umbricht, A., Preston, K.L., Cadet JL. (2003). Methadone Treatment Induces Attenuation of Cerebrovascular Deficits Associated with the Prolonged Abuse of Cocaine and Heroin. Neuropsychopharmacology, 28, 562-568.

Epstein, D.H., Hawkins, W.E., Covi, L., Umbricht, A., Preston, K.L. (2003). Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up. Psychology of Addictive Behaviors, 17, 73-82.

Montoya, I.D., Gorelick, D.A., Preston, K.L., Schroeder, J.R., Umbricht, A., Cheskin, L.J., Lange, W.R., Contoreggi, C., Johnson, R.E., Fudala, P.J. (2004). Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clinical Pharmacology and Therpeutics 75, 34-48.

Pickworth WB, Lee EM, Abreu ME, Umbricht A, Preston K.: A laboratory study of hydromorphone and cyclazocine on smoking behavior in residential polydrug users. 2004 Pharmacology Biochemistry and Behavior 77(4): 711-5.

Preston KL, Umbricht A, Schroeder JR, Abreu ME, Epstein DH, Pickworth WB: Cyclazocine: comparison to hydromorphone and interaction with cocaine. 2004 Behavioral Pharmacology 15(2): 91-102.

Boyd, S.J., Thomas-Gosain, N.F., Umbricht, A., Tucker, M.J., Leslie, J.M., Chaisson, R.E., Preston, K.L. (2004). Gender differences in indices of opioid dependency and medical comorbidity in a population of hospitalized HIV-infected African-Americans. The American Journal on Addictions 13, 281-291

Umbricht A., M. A. Huestis, E.J. Cone, K.L. Preston : "Effects of high-dose intravenous buprenorphine in experienced opioid abusers." 2004 Journal of Clinical Psychopharmacology 24(5): 479-87.

Montoya, I.D., Schroeder, J.R., Preston, K.L., Covi, L., Umbricht, A., Contoreggi, C., Fudala, P.J., Johnson, R.E., & Gorelick, D.A. Influence of psychotherapy attendance on buprenorphine treatment outcome. Journal of Substance Abuse Treatment, 28, 247-54, 2005.

Schroeder JR, Epstein DH, Umbricht A, Preston KL. (2006). "Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence." Addictive Behaviors 31(5): 868-79. 2006

Lanier RK, Umbricht A, Harrison JA, Nuwayser ES, Bigelow GE (2007). "Evaluation of a transdermal buprenorphine formulation in opioid detoxification." Addiction 102(10): 1648-56.

Lanier RK, Umbricht A, Harrison JA, Nuwayser ES, Bigelow GE (2008). "Opioid detoxification via single 7-day application of a buprenorphine transdermal patch: an open-label evaluation." Psychopharmacology (Berl) 198(2): 149-58.

Epstein, D. H., Schmittner, J., Umbricht, A., Schroeder, J. R., Moolchan, E. T., & Preston, K. L. (2009). Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency. Drug and Alcohol Dependence, 101(1-2), 92-100.

Wash, S. L., Donny, E. C., Nuzzo, P. A., Umbricht, A., & Bigelow, G. E. (2009). Cocaine abuse versus cocaine dependence: Cocaine self-administration and pharmacodynamic response in the human laboratory. Drug and Alcohol Dependence.


E-mail contact: annieumbricht@jhu.edu

Updated: 2/1/2010
http://bpru.med.jhu.edu/bio/umbricht.html